2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow brivanib: new trials by email Literature Review of brivanib trials Research Report on brivanib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients MGD013 monotherapy, MGD013 in combination with Brivanib Alaninate - Advanced Hepatocellular Carcinoma (HCC) | Phase 1 / Phase 2 | Terminated | Zai Lab (Shanghai) Co., Ltd. | 89 | 2020-04-20 | 2024-07-23 |
| Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies BMS-582664 - Gastrointestinal Neoplasms | Phase 1 | Terminated | Bristol-Myers Squibb | 50 | 2006-04-01 | 2010-03-02 |
Gastrointestinal Neoplasms (1)
Bristol-Myers Squibb (1) · Zai Lab (Shanghai) Co., Ltd. (1)
China (1) · United States (1)